Search results for: Multi-Indication Medicines
Filter search results
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development
23 August 2016
…HTA SA across Europe and promote the integration of HTA SA with the advice provided by regulatory authorities (Medicines and Healthcare products Regulatory Agency, MHRA, and European Medicines Agency, EMA)….
Does Government Funding Increase Public Sector Development of New Medicines?
5 March 2021
…medicines. To answer this question, a paper published last week by Dimitrios Kourouklis (2021), Senior Economist at OHE, quantifies the effect of public subsidies for research and development (R&D) on public…
Medicines in the 1990s: a Technological Forecast
1 July 1969
By 1990, the total cost of the National Health Service will probably have reached about £10,000 million of which about £1,300 million will be for medicines prescribed by general practitioners…
Medicines Which Affect the Mind
10 January 1975
…with the antibiotics in the 1940s and 1950s. Yet other informed individuals see the recent expansion of psychiatric treatment based on tranquillisers and kindred medicines as a significant threat to…
Medicines for the year 2000
1 September 1979
…profitably say a few words about the pharmaceutical industry in Britain at the present time. On reflection this is by no means inappropriate to a consideration of medicines for the…
Medicines: 50 Years of Progress 1930-1980
7 January 1980
…limits of space and time which have constrained our text in two main aspects. First, we have chronicled the development of new medicines by way of groupings related to the…
Cost-Benefit Analysis of Medicines – a Guide for Industry
1 January 1989
…medicines. Second, to remind readers why such analyses are of increasing importance both… The objectives of this booklet are twofold. First, to describe in simple terms the state of the…
Uses of Models in Economic Evaluations of Medicines and Other Health Technologies
1 October 1996
The use of models in economic studies evaluating medicines and other health technologies has become a controversial issue. This is because study results now matter – decision makers are increasingly…
Influencing Prescribing in a Primary Care Led NHS
11 January 2002
…objective included a postal survey and a review of the implementation literature. Medicines… The aim of the project was to evaluate the likely success of medicines management in a primary…